Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01364727 |
|---|---|
| Brief Title: | A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies |
| First Submitted : | May 31, 2011 |
| First Submitted that Met QC Criteria : | May 31, 2011 |
| First Posted : | June 2, 2011 (Estimate) |
| Results First Submitted : | January 23, 2017 |
| Results First Submitted that Met QC Criteria : | January 23, 2017 |
| Results First Posted : | March 14, 2017 |
| Last Update Submitted that Met QC Criteria : | April 5, 2019 |
| Last Update Posted : | April 16, 2019 |